[go: up one dir, main page]

WO2015151190A1 - Method for producing irsogladine maleate - Google Patents

Method for producing irsogladine maleate Download PDF

Info

Publication number
WO2015151190A1
WO2015151190A1 PCT/JP2014/059529 JP2014059529W WO2015151190A1 WO 2015151190 A1 WO2015151190 A1 WO 2015151190A1 JP 2014059529 W JP2014059529 W JP 2014059529W WO 2015151190 A1 WO2015151190 A1 WO 2015151190A1
Authority
WO
WIPO (PCT)
Prior art keywords
irsogladine
solution
maleic acid
methyl cellosolve
dichlorophenyl
Prior art date
Application number
PCT/JP2014/059529
Other languages
French (fr)
Japanese (ja)
Inventor
正之 服部
Original Assignee
日本新薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本新薬株式会社 filed Critical 日本新薬株式会社
Priority to PCT/JP2014/059529 priority Critical patent/WO2015151190A1/en
Priority to CN201480000788.4A priority patent/CN104245682B/en
Publication of WO2015151190A1 publication Critical patent/WO2015151190A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines

Definitions

  • the present invention relates to a method for producing 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine maleate.
  • irsogladine 2,4-Diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine
  • Is useful as a therapeutic agent for mucosal protective gastritis / gastric ulcer Patent Document 1.
  • irsogladine maleate is already marketed as Gaslon N (registered trademark).
  • Irsogladine maleate can be produced by heating and dissolving in a polar solvent such as methyl cellosolve and cooling in the presence of irsogladine and maleic acid. In order to produce on a commercial scale, it is important to efficiently obtain a high-purity target with a high yield. On the other hand, in the production of irsogladine maleate, irsogladine has low solubility in a solvent and needs to be heated for a long time in order to dissolve it.
  • An object of the present invention is to provide a method for producing a high yield and high purity irsogladine maleate.
  • the present inventor once dissolved irsogladine while heating in a polar solvent such as methyl cellosolve, and then added maleic acid to the heated solution to obtain a homogeneous solution. Then, by cooling, it was found for the first time that the crystals could be obtained in good yield by suppressing the coloration of the crystals, that is, this method could be produced on a commercial scale, and the present invention was completed based on these findings. .
  • a polar solvent such as methyl cellosolve
  • the present invention can include the following inventions (I) to (IV).
  • (I) A process for producing maleate crystals of 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine, comprising the following (A), (B), and ( A production method including the step C): (A) a step of once dissolving 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine in an organic solvent with heating and stirring; (B) A step of adding maleic acid to the solution of (A) to make a uniform solution; (C) A step of cooling the solution to room temperature and isolating the precipitated crystals.
  • the organic solvent used is methyl cellosolve, and the maleic acid used is 0.8-fold mol with respect to 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine.
  • Irsogladine which is a starting material used in the present invention, can be produced by the method described in Patent Document 1.
  • a method for practicing the present invention to produce irsogladine maleate is provided.
  • This method is a method for producing crystals of 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine maleate, and includes the following (A), (B), and ( A production method including the step C): (A) a step of dissolving 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine in an organic solvent under heating and stirring to form a uniform solution; (B) A step of adding maleic acid to the solution of (A) to make a uniform solution; (C) A step of cooling the solution to room temperature and isolating the precipitated crystals.
  • the solvent used in the present invention is not particularly limited as long as it dissolves the starting material and does not inhibit the reaction, and examples thereof include alcohol solvents such as methanol, ethanol, methyl cellosolve (also referred to as 2-methoxyethanol). it can. Of these, methyl cellosolve or ethanol is preferable, and methyl cellosolve is more preferable.
  • the amount of the solvent used is usually preferably 5 mL to 50 mL, more preferably 5 mL to 15 mL, and most preferably 10 mL per 1 g of irsogladine as a raw material.
  • the temperature at which irsogladine and maleic acid are dissolved is preferably kept at 80 ° C. from the viewpoint of preventing the precipitation of irsogladine and improving the reaction efficiency.
  • the amount of maleic acid used in the present invention is usually preferably 0.8 mol to 5.0 mol, more preferably 1.0 mol to 1.4 mol, and more preferably 1.0 to 1.2 mol with respect to 1 mol of irsogladine. Is most preferred.
  • maleic acid In the case of adding maleic acid, it may be added all at once, or may be added in several to tens of times.
  • seed crystals may be added.
  • the seed crystal is preferably added after the irsogladine is completely dissolved, and more preferably added at 80 ° C.
  • the amount of seed crystals added is preferably 0.1% by weight to 10% by weight with respect to irsogladine used in the step (1).
  • the dotted line is the wavy line
  • the solid line is the yield of irsogladine maleic acid when using 1.0 molar equivalents of maleic acid (Reference Examples 1 and 2)
  • the broken line is the irsogladine maleic acid when using 1.2 molar equivalents of maleic acid Yield (Reference Examples 3 and 4)
  • the solid line represents the yield when 1.2 molar equivalents of maleic acid were added after heating and dissolving irsogladine (Examples 1 and 2).
  • Example 2 Ilsogladine (2.0 g, 7.8 mmol) was heated to 80 ° C. with stirring in methyl cellosolve (20 ml) and stirred for 7 hours to completely dissolve the above mixture, and then maleic acid (1.1 g , 9.4 mmol), and stirred at 80 ° C. for 15 minutes. The reaction solution was allowed to stand at room temperature for 40 hours, and the resulting crystals were separated. After washing with methyl cellosolve and drying, irsogladine maleate (62%) was obtained.
  • Example 2 Ilsogladine (2.0 g, 7.8 mmol) was heated to 80 ° C. with stirring in methyl cellosolve (20 ml) and stirred for 7 hours to completely dissolve the above mixture, and then maleic acid (1.1 g , 9.4 mmol), and stirred at 80 ° C. for 15 minutes. The reaction solution was allowed to stand at room temperature for 40 hours, and the resulting crystals were separated. After washing with methyl cellosolve and drying,
  • Table 1 below shows the amount of maleic acid used in Reference Examples 1 to 4 and Examples 1 and 2, heating and stirring time and yield, and coloration of crystals.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Provided is a method for producing high-purity irsogladine maleate with high yield while reducing the production of a by-product. 2,4-diamino-6-(2,5-dichlorophenyl)-1,3,5-triazine is dissolved in an organic solvent while heating and stirring to prepare a solution, then maleic acid is added and dissolved in the solution, and then the resultant solution is cooled to room temperature. In this manner, crystals can be produced with high yield while preventing the coloration of the crystals.

Description

イルソグラジンマレイン酸塩の製造方法Method for producing irsogladine maleate
 本発明は、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンマレイン酸塩の製造方法に関する。 The present invention relates to a method for producing 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine maleate.
 2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジン(以下、イルソグラジンと呼ぶ)は以下の式(I)で表され、イルソグラジン又はその医薬上許容される塩は粘膜防御性胃炎・胃潰瘍治療剤として有用である(特許文献1)。中でもイルソグラジンのマレイン酸塩はガスロンN(登録商標)としてすでに上市されている。
Figure JPOXMLDOC01-appb-C000001
                  
2,4-Diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine (hereinafter referred to as irsogladine) is represented by the following formula (I), and irsogladine or a pharmaceutically acceptable salt thereof: Is useful as a therapeutic agent for mucosal protective gastritis / gastric ulcer (Patent Document 1). Among them, irsogladine maleate is already marketed as Gaslon N (registered trademark).
Figure JPOXMLDOC01-appb-C000001
 イルソグラジンマレイン酸塩はイルソグラジン及びマレイン酸共存下、メチルセロソルブ等の極性溶媒中、加熱溶解後、冷却することによって製造することができる。商業規模で製造するためには、高い収率で、高い純度の目的物を効率よく得ることが重要である。一方、イルソグラジンマレイン酸塩の製造において、イルソグラジンは溶媒に対する溶解性が低く、溶解させるために長時間加熱する必要があるが、前述の方法で製造すると、加熱溶解の時間に応じてイルソグラジンマレイン酸塩の収量がが経時的に減少していくだけでなく、結晶の着色が顕著になるため、商業的に十分満足できるものとは言い難く、更に優れたイルソグラジンマレイン酸塩の製造方法の開発が望まれていた。
 
Irsogladine maleate can be produced by heating and dissolving in a polar solvent such as methyl cellosolve and cooling in the presence of irsogladine and maleic acid. In order to produce on a commercial scale, it is important to efficiently obtain a high-purity target with a high yield. On the other hand, in the production of irsogladine maleate, irsogladine has low solubility in a solvent and needs to be heated for a long time in order to dissolve it. Not only does the yield of ginmaleate decrease over time, but the coloration of the crystals becomes noticeable, so it is difficult to say that it is sufficiently satisfactory commercially, and the production of a better irsogladine maleate Development of a method was desired.
特許第1249105号Patent No. 1249105
 本発明の目的は、高収率かつ、高純度のイルソグラジンマレイン酸塩の製造方法を提供することにある。
 
An object of the present invention is to provide a method for producing a high yield and high purity irsogladine maleate.
 本発明者は、上記の問題を解決すべく鋭意研究を行った結果、イルソグラジンをメチルセロソルブ等の極性溶媒中で加熱しながら一旦溶解した後、当該加熱溶液中にマレイン酸を加え、均一溶液とし、その後冷却することにより、結晶の着色を抑え、収率よく結晶を得ることができ、すなわちこの方法が商業的なスケールで製造できることを初めて見出し、これらの知見に基づいて本発明を完成させた。
 
As a result of diligent research to solve the above problems, the present inventor once dissolved irsogladine while heating in a polar solvent such as methyl cellosolve, and then added maleic acid to the heated solution to obtain a homogeneous solution. Then, by cooling, it was found for the first time that the crystals could be obtained in good yield by suppressing the coloration of the crystals, that is, this method could be produced on a commercial scale, and the present invention was completed based on these findings. .
 すなわち、本発明は、以下の(I)~(IV)の発明を挙げることができる。 That is, the present invention can include the following inventions (I) to (IV).
(I)2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンのマレイン酸塩の結晶の製造方法であって、下記(A)、(B)、及び(C)の工程を含む製造方法:
(A)2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンを有機溶媒中、加熱撹拌下溶解させて一旦溶液を形成する工程;
(B)上記(A)の溶液に、マレイン酸を加えて均一溶液とする工程;
(C)その溶液を室温まで冷却し、析出した結晶を単離する工程。
(II)使用する有機溶媒がメチルセロソルブである、上記(I)に記載の製造方法。
(III)使用するマレイン酸が、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンに対し、0.8倍モル~5.0倍モル当量である、(I)又は(II)に記載の製造方法。
(IV)上記(A)の溶液において、加熱撹拌時の温度が50℃~100℃である(I)~(III)いずれかに記載の製造方法。
(V)使用する有機溶媒がメチルセロソルブであり、使用するマレイン酸が、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンに対し、0.8倍モル~5.0倍モル当量であり、上記(A)の溶液において、加熱撹拌時の温度が50℃~100℃である上記(I)に記載の製造方法。
 
(I) A process for producing maleate crystals of 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine, comprising the following (A), (B), and ( A production method including the step C):
(A) a step of once dissolving 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine in an organic solvent with heating and stirring;
(B) A step of adding maleic acid to the solution of (A) to make a uniform solution;
(C) A step of cooling the solution to room temperature and isolating the precipitated crystals.
(II) The production method according to (I) above, wherein the organic solvent used is methyl cellosolve.
(III) The maleic acid used is 0.8-fold to 5.0-fold molar equivalents relative to 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine. The manufacturing method as described in (I) or (II).
(IV) The production method according to any one of (I) to (III), wherein the temperature of heating and stirring in the solution of (A) is 50 ° C. to 100 ° C.
(V) The organic solvent used is methyl cellosolve, and the maleic acid used is 0.8-fold mol with respect to 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine. The production method according to (I), wherein the molar equivalent is ˜5.0 times, and the temperature during heating and stirring is 50 ° C. to 100 ° C. in the solution of (A).
 本発明によれば、経時的なイルソグラジンの減少を抑え、着色のない高純度のイルソグラジンマレイン酸塩を得ることができる。
 
According to the present invention, it is possible to obtain a highly pure irsogladine maleate with no coloration, while suppressing a decrease in irsogladine over time.
 本発明で使用する出発原料であるイルソグラジンは、特許文献1に記載の方法により製造することができる。 Irsogladine, which is a starting material used in the present invention, can be produced by the method described in Patent Document 1.
 本発明を実施してイルソグラジンマレイン酸塩を製造する方法を提供する。この方法は、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンマレイン酸塩の結晶の製造方法であって、下記(A)、(B)、及び(C)の工程を含む製造方法:
(A)2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンを有機溶媒中、加熱撹拌下溶解させて均一溶液を形成する工程;
(B)上記(A)の溶液に、マレイン酸加えて均一溶液とする工程;
(C)その溶液を室温まで冷却し、析出した結晶を単離する工程である。
A method for practicing the present invention to produce irsogladine maleate is provided. This method is a method for producing crystals of 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine maleate, and includes the following (A), (B), and ( A production method including the step C):
(A) a step of dissolving 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine in an organic solvent under heating and stirring to form a uniform solution;
(B) A step of adding maleic acid to the solution of (A) to make a uniform solution;
(C) A step of cooling the solution to room temperature and isolating the precipitated crystals.
 本発明において使用する溶媒は、出発物質を溶解し、反応を阻害しなければ特に限定はなく、例えば、メタノール、エタノール、メチルセロソルブ(2-メトキシエタノールともいう)等のアルコール系溶媒を挙げることができる。中でもメチルセロソルブ又はエタノールが好ましく、メチルセロソルブがより好ましい。溶媒の使用量は、原料のイルソグラジン1gに対し、通常5mL~50mLが好ましく、5mL~15mLがより好ましく、10mLが最も好ましい。 The solvent used in the present invention is not particularly limited as long as it dissolves the starting material and does not inhibit the reaction, and examples thereof include alcohol solvents such as methanol, ethanol, methyl cellosolve (also referred to as 2-methoxyethanol). it can. Of these, methyl cellosolve or ethanol is preferable, and methyl cellosolve is more preferable. The amount of the solvent used is usually preferably 5 mL to 50 mL, more preferably 5 mL to 15 mL, and most preferably 10 mL per 1 g of irsogladine as a raw material.
 イルソグラジンおよびマレイン酸を溶解する温度は、イルソグラジンが析出するのを防止し、反応効率を向上させる観点から、80℃に保っておくことが望ましい。 The temperature at which irsogladine and maleic acid are dissolved is preferably kept at 80 ° C. from the viewpoint of preventing the precipitation of irsogladine and improving the reaction efficiency.
 本発明におけるマレイン酸の使用量はイルソグラジン1モルに対して、通常0.8モル~5.0モルが好ましく、1.0モル~1.4モルがより好ましく、1.0~1.2モルが最も好ましい。 The amount of maleic acid used in the present invention is usually preferably 0.8 mol to 5.0 mol, more preferably 1.0 mol to 1.4 mol, and more preferably 1.0 to 1.2 mol with respect to 1 mol of irsogladine. Is most preferred.
 マレイン酸を加える場合には、一度に全部を加えてもよいし、数回~十数回程度に分けて加えてもよい。 In the case of adding maleic acid, it may be added all at once, or may be added in several to tens of times.
 結晶化の際には、種晶を添加してもよい。種晶の添加による効果をより向上させるため、種晶はイルソグラジンが完全に溶解した後に添加するのが好ましく、80℃で添加することがより望ましい。 In the case of crystallization, seed crystals may be added. In order to further improve the effect of addition of the seed crystal, the seed crystal is preferably added after the irsogladine is completely dissolved, and more preferably added at 80 ° C.
 種晶の添加量は、上記工程(1)で使用するイルソグラジンに対して0.1重量%~10重量%が好ましい。
 
The amount of seed crystals added is preferably 0.1% by weight to 10% by weight with respect to irsogladine used in the step (1).
マレイン酸とイルソグラジンのメチルセロソルブ溶液の加温時間とイルソグラジンマレイン酸塩の生成収率との関係を表す図であり、縦軸は収率、横軸は溶液の加熱撹拌した時間を表す。点線は波線は実線はマレイン酸1.0モル当量使用時のイルソグラジンマレイン酸の収率(参考例1及び2)、破線はマレイン酸1.2モル当量使用時のイルソグラジンマレイン酸の収率(参考例3及び4)、実線はイルソグラジンを加熱溶解後にマレイン酸1.2モル当量を加えた時の収率を表す(実施例1及び2)。It is a figure showing the relationship between the heating time of the methyl cellosolve solution of maleic acid and irsogladine, and the production | generation yield of irsogladine maleate, A vertical axis | shaft represents a yield and a horizontal axis | shaft represents the time which heated and stirred the solution. The dotted line is the wavy line, the solid line is the yield of irsogladine maleic acid when using 1.0 molar equivalents of maleic acid (Reference Examples 1 and 2), and the broken line is the irsogladine maleic acid when using 1.2 molar equivalents of maleic acid Yield (Reference Examples 3 and 4), the solid line represents the yield when 1.2 molar equivalents of maleic acid were added after heating and dissolving irsogladine (Examples 1 and 2).
 以下に、実施例を掲げて本発明を更に詳しく説明するが、本発明はこれらのみに限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
参考例1
 反応容器にメチルセロソルブ(200mL)を注入し、80℃に加熱した。ここにイルソグラジン(20.0g,78.1mmol)及びマレイン酸(9.1g、78.1mmol、イルソグラジンに対するモル比1.0)を加え、80℃で5時間撹拌し、上記の混合物を完全に溶解させた。反応液からその一部を分取し、分取した反応液からイルソグラジンマレイン酸塩を結晶化させ、メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(58%)を得た。
 
参考例2
 反応容器にメチルセロソルブ(200mL)を注入し、80℃に加熱した。ここにイルソグラジン(20.0g,78.1mmol)及びマレイン酸(9.1g、78.1mmol、イルソグラジンに対するモル比1.0)を加え、80℃で7時間撹拌し、上記の混合物を完全に溶解させた。反応液からその一部を分取し、分取した反応液からイルソグラジンマレイン酸塩を結晶化させ、メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(47%)を得た。
 
参考例3
 反応容器にメチルセロソルブ(200mL)を注入し、80℃に加熱した。ここにイルソグラジン(20.0g,78.1mmol)及びマレイン酸(10.9g、93.7mmol、イルソグラジンに対するモル比1.2)を加え、80℃で5時間撹拌し、上記の混合物を完全に溶解させた。反応液からその一部を分取し、分取した反応液からイルソグラジンマレイン酸塩を結晶化させ、メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(55%)を得た。
 
参考例4
 反応容器にメチルセロソルブ(200mL)を注入し、80℃に加熱した。ここにイルソグラジン(20.0g,78.1mmol)及びマレイン酸(10.9g、93.7mmol、イルソグラジンに対するモル比1.2)を加え、80℃で7時間撹拌し、上記の混合物を完全に溶解させた。反応液からその一部を分取し、分取した反応液からイルソグラジンマレイン酸塩を結晶化させ、メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(48%)を得た。
 
実施例1
 イルソグラジン(2.0g,7.8mmol)をメチルセロソルブ(20ml)中で撹拌しながら80℃に加熱して5時間撹拌し、上記の混合物を完全に溶解させた後、、マレイン酸(1.1g、9.4mmol)を加え、80℃で15分間撹拌した。反応液を40時間室温に放置し、生じた結晶を分離した。メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(62%)を得た。
 
実施例2
 イルソグラジン(2.0g,7.8mmol)をメチルセロソルブ(20ml)中で撹拌しながら80℃に加熱して7時間撹拌し、、上記の混合物を完全に溶解させた後、マレイン酸(1.1g、9.4mmol)を加え、80℃で15分間撹拌した。反応液を40時間室温に放置し、生じた結晶を分離した。メチルセロソルブで洗浄後、乾燥してイルソグラジンマレイン酸塩(64%)を得た。
 
Reference example 1
Methyl cellosolve (200 mL) was poured into the reaction vessel and heated to 80 ° C. Irsogladine (20.0 g, 78.1 mmol) and maleic acid (9.1 g, 78.1 mmol, molar ratio to irsogladine 1.0) were added thereto, and the mixture was stirred at 80 ° C. for 5 hours to completely dissolve the above mixture. I let you. A part of the reaction solution was collected, and irsogladine maleate was crystallized from the collected reaction solution, washed with methyl cellosolve, and dried to obtain irsogladine maleate (58%). .

Reference example 2
Methyl cellosolve (200 mL) was poured into the reaction vessel and heated to 80 ° C. Irsogladine (20.0 g, 78.1 mmol) and maleic acid (9.1 g, 78.1 mmol, molar ratio to irsogladine 1.0) were added thereto and stirred at 80 ° C. for 7 hours to completely dissolve the above mixture. I let you. A part of the reaction solution was collected, and irsogladine maleate was crystallized from the collected reaction solution, washed with methyl cellosolve, and dried to obtain irsogladine maleate (47%). .

Reference example 3
Methyl cellosolve (200 mL) was poured into the reaction vessel and heated to 80 ° C. Irsogladine (20.0 g, 78.1 mmol) and maleic acid (10.9 g, 93.7 mmol, molar ratio to irsogladine 1.2) were added thereto, and the mixture was stirred at 80 ° C. for 5 hours to completely dissolve the above mixture. I let you. A part of the reaction solution was collected, and irsogladine maleate was crystallized from the collected reaction solution, washed with methyl cellosolve, and dried to obtain irsogladine maleate (55%). .

Reference example 4
Methyl cellosolve (200 mL) was poured into the reaction vessel and heated to 80 ° C. Add irsogladine (20.0 g, 78.1 mmol) and maleic acid (10.9 g, 93.7 mmol, molar ratio to irsogladine 1.2) and stir at 80 ° C. for 7 hours to completely dissolve the above mixture. I let you. A part of the reaction solution was collected, and irsogladine maleate was crystallized from the collected reaction solution, washed with methyl cellosolve, and dried to obtain irsogladine maleate (48%). .

Example 1
Ilsogladine (2.0 g, 7.8 mmol) was heated to 80 ° C. with stirring in methyl cellosolve (20 ml) and stirred for 5 hours to completely dissolve the above mixture, and then maleic acid (1.1 g , 9.4 mmol), and stirred at 80 ° C. for 15 minutes. The reaction solution was allowed to stand at room temperature for 40 hours, and the resulting crystals were separated. After washing with methyl cellosolve and drying, irsogladine maleate (62%) was obtained.

Example 2
Ilsogladine (2.0 g, 7.8 mmol) was heated to 80 ° C. with stirring in methyl cellosolve (20 ml) and stirred for 7 hours to completely dissolve the above mixture, and then maleic acid (1.1 g , 9.4 mmol), and stirred at 80 ° C. for 15 minutes. The reaction solution was allowed to stand at room temperature for 40 hours, and the resulting crystals were separated. After washing with methyl cellosolve and drying, irsogladine maleate (64%) was obtained.
 参考例1~4、及び実施例1,2で使用したマレイン酸の量と加熱撹拌時間と収率、結晶の着色について下記の表1に示す。 Table 1 below shows the amount of maleic acid used in Reference Examples 1 to 4 and Examples 1 and 2, heating and stirring time and yield, and coloration of crystals.
Figure JPOXMLDOC01-appb-T000002
*使用したイルソグラジンに対するモル当量を表す
 
Figure JPOXMLDOC01-appb-T000002
* Represents the molar equivalent of irsogladine used.
 図1に示す通り、イルソグラジンとマレイン酸の混合物をメチルセロソルブに加熱溶解させる場合に比べ、イルソグラジンをメチルセロソルブに加熱溶解した後にマレイン酸を加えれば、経時的な収率の低下はなく、収率よくイルソグラジンマレイン酸塩の結晶を得ることができる。
 
As shown in FIG. 1, compared to the case where a mixture of irsogladine and maleic acid is heated and dissolved in methyl cellosolve, if maleic acid is added after irsogladine is heated and dissolved in methyl cellosolve, the yield does not decrease over time. Crystals of irsogladine maleate can be obtained well.

Claims (5)

  1. 2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンマレイン酸塩の結晶の製造方法であって、下記(i)~(iii)の工程を含む製造方法:
    (i)2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンを有機溶媒中、加熱撹拌下溶解させて均一溶液を形成する工程;
    (ii)上記(i)の溶液に、マレイン酸を加えて均一溶液とする工程;
    (iii)その溶液を室温まで冷却し、析出した結晶を単離することを含む工程。
    A method for producing crystals of 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine maleate, which comprises the following steps (i) to (iii):
    (I) a step of dissolving 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine in an organic solvent under heating and stirring to form a uniform solution;
    (Ii) a step of adding maleic acid to the solution of (i) to make a uniform solution;
    (Iii) cooling the solution to room temperature and isolating the precipitated crystals.
  2. 使用する有機溶媒がメチルセロソルブである、請求項1に記載の製造方法。 The manufacturing method of Claim 1 whose organic solvent to be used is methyl cellosolve.
  3. 使用するマレイン酸が、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンに対し、1.0倍モル~5.0倍モル当量である、請求項1又は請求項2に記載の製造方法。 2. The maleic acid to be used is 1.0-fold to 5.0-fold molar equivalent to 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine. Or the manufacturing method of Claim 2.
  4. 上記(i)の溶液において、加熱撹拌時の温度が50℃~100℃である請求項1~3いずれかに記載の製造方法。 The production method according to any one of claims 1 to 3, wherein in the solution (i), the temperature at the time of heating and stirring is 50 ° C to 100 ° C.
  5. 使用する有機溶媒がメチルセロソルブであり、使用するマレイン酸が、2,4-ジアミノ-6-(2,5-ジクロロフェニル)-1,3,5-トリアジンに対し、1.0倍モル~5.0倍モル当量であり、上記(i)の溶液において、加熱撹拌時の温度が50℃~100℃である請求項1に記載の製造方法。
     
    The organic solvent to be used is methyl cellosolve, and the maleic acid to be used is 1.0 times mol to 5.times.5 with respect to 2,4-diamino-6- (2,5-dichlorophenyl) -1,3,5-triazine. The production method according to claim 1, wherein the molar amount is 0 times, and the temperature during heating and stirring is 50 to 100 ° C in the solution of (i).
PCT/JP2014/059529 2014-03-31 2014-03-31 Method for producing irsogladine maleate WO2015151190A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/JP2014/059529 WO2015151190A1 (en) 2014-03-31 2014-03-31 Method for producing irsogladine maleate
CN201480000788.4A CN104245682B (en) 2014-03-31 2014-03-31 The manufacturing method of irsogladine maleate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2014/059529 WO2015151190A1 (en) 2014-03-31 2014-03-31 Method for producing irsogladine maleate

Publications (1)

Publication Number Publication Date
WO2015151190A1 true WO2015151190A1 (en) 2015-10-08

Family

ID=52231752

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/059529 WO2015151190A1 (en) 2014-03-31 2014-03-31 Method for producing irsogladine maleate

Country Status (2)

Country Link
CN (1) CN104245682B (en)
WO (1) WO2015151190A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106187928B (en) * 2016-08-02 2019-06-07 安徽省逸欣铭医药科技有限公司 A kind of preparation method of irsogladine maleate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5824514A (en) * 1981-08-04 1983-02-14 Nippon Shinyaku Co Ltd Remedy for peptic ulcer
JPS5855423A (en) * 1981-09-25 1983-04-01 Nippon Shinyaku Co Ltd Drug containing benzoguanamine as principal component
JPH0770090A (en) * 1993-09-01 1995-03-14 Taiyo Yakuhin Kogyo Kk Production of irsogladine and its acid addition salt

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5824514A (en) * 1981-08-04 1983-02-14 Nippon Shinyaku Co Ltd Remedy for peptic ulcer
JPS5855423A (en) * 1981-09-25 1983-04-01 Nippon Shinyaku Co Ltd Drug containing benzoguanamine as principal component
JPH0770090A (en) * 1993-09-01 1995-03-14 Taiyo Yakuhin Kogyo Kk Production of irsogladine and its acid addition salt

Also Published As

Publication number Publication date
CN104245682A (en) 2014-12-24
CN104245682B (en) 2019-04-05

Similar Documents

Publication Publication Date Title
WO2017096772A1 (en) Method for preparing anti-heart-failure medicine lcz696
US9120782B2 (en) Method for preparation of iloperidone and crystallization method thereof
JP2012500819A5 (en)
JP2011527330A5 (en)
JPWO2011007895A1 (en) Process for producing crystalline polymorph of 2- (3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecarboxylic acid by a poor solvent addition method
JP7379470B2 (en) Method of preparation of lenvatinib
JP2014508805A (en) Method for producing pemetrexed salt
JP6014912B2 (en) Process for the production of bendamustine alkyl esters, bendamustine, and their derivatives
CN104829590B (en) Method for purifying trelagliptin
WO2015151190A1 (en) Method for producing irsogladine maleate
WO2017199903A1 (en) Crystal of quinoline derivative
CN104447758B (en) The synthesis technique of pyrazolo [3,4 d] pyrimidines
JP5827684B2 (en) Method for preparing crystalline form A of 2- [3-cyano-4- (2-i-butoxy) phenyl] -4-methyl-5-thiazole-carboxylic acid (febuxostat)
JP2011519840A (en) Preparation of 1,7'-dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole
KR20180123851A (en) Novel crystal form of lenalidomide and preparation of the same
TWI443100B (en) Process for the production of a pemetrexed salt
WO2016034150A1 (en) Method for preparing bosutinib and crystal thereof
CN116034103A (en) Method for producing 1,3,4-oxadiazol-2-amine compound
JP6147432B2 (en) Method for producing type II crystals of sarpogrelate hydrochloride
JP6802815B2 (en) Method for producing dichloroquinone derivative
CN104628647A (en) Preparation method of 3-methyl-1-(3,4-dimethylphenyl)-2-pyrazoline-5-one
CN103360307B (en) Preparation method of 5-chloro-2,4-dihydroxypyridine
US20230286898A1 (en) Method for the purification of vilanterol trifenatate
CN106478484A (en) A kind of method preparing Almogran key intermediate
CN106432221B (en) A kind of process for purification of Homatropine Methylbromide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14887874

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14887874

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP